Provided by Tiger Trade Technology Pte. Ltd.

PTC Therapeutics

70.03
+0.20500.29%
Volume:257.72K
Turnover:17.82M
Market Cap:5.84B
PE:-114.80
High:70.10
Open:69.67
Low:68.02
Close:69.82
52wk High:90.87
52wk Low:48.28
Shares:83.46M
Float Shares:77.19M
Volume Ratio:0.70
T/O Rate:0.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6100
EPS(LYR):7.78
ROE:-7740.12%
ROA:2.46%
PB:-35.34
PE(LYR):9.00

Loading ...

PTC Therapeutics Reports New Sephience PKU Trial and Real-World Data Showing Sustained Phe Control, Diet Liberalization

Reuters
·
Yesterday

PTC Therapeutics Director Michael Schmertzler Sells 24,000 Shares for $1.73 Million

Reuters
·
Aug 22

PTC Therapeutics Steps Into Rheumatoid Arthritis With New Phase 2 Study of PTC844

TIPRANKS
·
Aug 22

PTC Therapeutics Exec. VP and CLO Mark Elliott Boulding Disposes of 2,813 Common Shares Worth $204,863.91

Reuters
·
Aug 20

The Bull Case For PTC Therapeutics (PTCT) Could Change Following Renal Data Progress For ST-920

Simply Wall St.
·
Aug 20

PTC Therapeutics Sets Up Long-Term FA Study, Adding a New Catalyst for PTCT Investors

TIPRANKS
·
Aug 15

PTC Therapeutics : Barclays Raises Target Price to $122 from $120

THOMSON REUTERS
·
Aug 14

Barclays Sticks to Their Buy Rating for PTC Therapeutics (PTCT)

TIPRANKS
·
Aug 14

Cantor Fitzgerald Sticks to Their Buy Rating for PTC Therapeutics (PTCT)

TIPRANKS
·
Aug 13

Bank of America Securities Reaffirms Their Buy Rating on PTC Therapeutics (PTCT)

TIPRANKS
·
Aug 13

PTC Therapeutics to Acquire ST-920 Fabry Gene Therapy

TIPRANKS
·
Aug 13

PTC Therapeutics, Inc. : Wells Fargo Raises Target Price to $109 from $106

THOMSON REUTERS
·
Aug 13

Sangamo Selects Winning Bids in Chapter 11 Asset Auction for USD 163.55 Million Cash at Close

Reuters
·
Aug 13

PTC Therapeutics to Buy Sangamo’s ST-920 Fabry Gene Therapy Program for $111 Million Upfront

Reuters
·
Aug 13

PTC Therapeutics, - to Buy St-920 Gene Therapy for Fabry Disease from Sangamo

THOMSON REUTERS
·
Aug 13

PTC Therapeutics, - Rolling Bla Submission for St-920 Expected to Complete in Q4 2026

THOMSON REUTERS
·
Aug 13

PTC Therapeutics, - Deal Terms Include $111 Mln Upfront and up to $100 Mln in Milestone Payments

THOMSON REUTERS
·
Aug 13

PTC to Expand Rare Disease Portfolio with Acquisition of Bla-Stage St-920 Fabry Disease Program

THOMSON REUTERS
·
Aug 13

Press Release: PTC to Expand Rare Disease Portfolio with Acquisition of BLA-Stage ST-920 Fabry Disease Program

Dow Jones
·
Aug 13

Barclays Keeps Their Buy Rating on PTC Therapeutics (PTCT)

TIPRANKS
·
Aug 03